17-Apr-2026
No headlines found.
CareTrust REIT Announces $119 Million of Recent Investments; Reloaded Pipeline
Business Wire (Mon, 6-Apr 4:36 PM ET)
CareTrust REIT Raises Quarterly Dividend to $0.39 per Share
Business Wire (Fri, 13-Mar 6:00 AM ET)
PRNewswire (Fri, 6-Mar 6:40 PM ET)
Globe Newswire (Mon, 23-Feb 8:30 AM ET)
CareTrust REIT Announces Fourth Quarter & Full Year 2025 Operating Results
Business Wire (Thu, 12-Feb 4:13 PM ET)
CareTrust REIT Sets Fourth Quarter Earnings Call for Friday, February 13, 2026
Business Wire (Wed, 28-Jan 5:30 PM ET)
CareTrust REIT, Inc. Announces Tax Treatment of 2025 Dividends
Business Wire (Mon, 26-Jan 7:00 AM ET)
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.
Caretrust REIT trades on the NYSE stock market under the symbol CTRE.
As of April 17, 2026, CTRE stock price was flat at $39.50 with 1,577,794 million shares trading.
CTRE has a beta of 0.39, meaning it tends to be less sensitive to market movements. CTRE has a correlation of 0.08 to the broad based SPY ETF.
CTRE has a market cap of $8.82 billion. This is considered a Mid Cap stock.
Last quarter Caretrust REIT reported $135 million in Revenue and $.47 earnings per share. This beat revenue expectation by $362,396 and exceeded earnings estimates by $.05.
In the last 3 years, CTRE traded as high as $41.72 and as low as $18.18.
The top ETF exchange traded funds that CTRE belongs to (by Net Assets): VNQ, IJH, VTI, IWM, VB.
CTRE has outperformed the market in the last year with a return of +42.2%, while the SPY ETF gained +36.3%. In the last 3 month period, CTRE beat the market returning +5.6%, while SPY returned +2.9%. However, in the most recent 2 weeks CTRE has underperformed the stock market by returning +3.1%, while SPY returned +8.3%.
CTRE support price is $38.80 and resistance is $40.21 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTRE shares will trade within this expected range on the day.